• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50years of age and older: A systematic review and meta-analysis" [Vaccine 34 (2016) 1540-1550].

作者信息

Kraicer-Melamed Hannah, O'Donnell Shauna, Quach Caroline

机构信息

Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, QC, Canada; MUHC Vaccine Study Centre - Research Institute, McGill University Health Centre, Montreal, QC, Canada.

Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, QC, Canada; MUHC Vaccine Study Centre - Research Institute, McGill University Health Centre, Montreal, QC, Canada; Department of Pediatrics, Division of Infectious Diseases, McGill University, Montreal, QC, Canada; Quebec Institute of Public Health, Montreal, QC, Canada.

出版信息

Vaccine. 2016 Jul 25;34(34):4083-4084. doi: 10.1016/j.vaccine.2016.06.045. Epub 2016 Jun 18.

DOI:10.1016/j.vaccine.2016.06.045
PMID:27329185
Abstract
摘要

相似文献

1
Corrigendum to "The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50years of age and older: A systematic review and meta-analysis" [Vaccine 34 (2016) 1540-1550].《23价肺炎球菌多糖疫苗（PPV23）在50岁及以上普通人群中的有效性：系统评价与荟萃分析》的勘误 [《疫苗》34卷（2016年）第1540 - 1550页]
Vaccine. 2016 Jul 25;34(34):4083-4084. doi: 10.1016/j.vaccine.2016.06.045. Epub 2016 Jun 18.
2
Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.联合抗逆转录病毒治疗时代，HIV感染成年患者的肺炎球菌疫苗接种情况。
Hum Vaccin Immunother. 2014;10(12):3700-10. doi: 10.4161/hv.32247.
3
23-valent pneumococcal polysaccharide vaccine (PPV23) for the prevention of invasive pneumococcal diseases (IPDs) in the elderly: is it really effective?用于预防老年人侵袭性肺炎球菌疾病（IPD）的23价肺炎球菌多糖疫苗（PPV23）：它真的有效吗？
J Prev Med Hyg. 2012 Jun;53(2):101-3.
4
Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and Wales.英格兰和威尔士 5-15 岁儿童侵袭性肺炎球菌病、合并症和多糖疫苗使用情况。
Clin Infect Dis. 2014 Feb;58(4):517-25. doi: 10.1093/cid/cit791. Epub 2013 Dec 2.
5
Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales.23 价肺炎球菌多糖疫苗对英格兰和威尔士老年人侵袭性肺炎球菌病的影响和效果。
Vaccine. 2012 Nov 6;30(48):6802-8. doi: 10.1016/j.vaccine.2012.09.019. Epub 2012 Sep 18.
6
Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in alaska native adults 55-70 years of age.55至70岁阿拉斯加原住民成年人中肺炎球菌多糖疫苗和结合疫苗的免疫原性及反应原性
Clin Infect Dis. 2009 Jul 15;49(2):241-8. doi: 10.1086/599824.
7
Pneumococcal vaccination in older adults in the era of childhood vaccination: Public health insights from a Norwegian statistical prediction study.儿童疫苗接种时代老年人的肺炎球菌疫苗接种：挪威一项统计预测研究的公共卫生见解
Epidemics. 2015 Jun;11:24-31. doi: 10.1016/j.epidem.2015.01.001. Epub 2015 Jan 19.
8
[Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age].[关于预防社区获得性肺炎的建议，以菌血症作为50岁以上人群及19岁以上风险群体侵袭性肺炎球菌感染的主要形式]
Pol Merkur Lekarski. 2014 Feb;36(212):79-87.
9
Immunogenicity and safety of pneumococcal conjugate polysaccharide and free polysaccharide vaccines alone or combined in HIV-infected adults in Brazil.巴西 HIV 感染者中肺炎球菌结合多糖和游离多糖疫苗单独或联合使用的免疫原性和安全性。
Vaccine. 2013 Aug 20;31(37):4047-53. doi: 10.1016/j.vaccine.2013.04.065. Epub 2013 May 16.
10
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study.23 价肺炎球菌多糖疫苗对 60 岁以上普通人群社区获得性肺炎的有效性：CAPAMIS 研究 3 年随访结果。
Clin Infect Dis. 2014 Apr;58(7):909-17. doi: 10.1093/cid/ciu002. Epub 2014 Feb 13.

引用本文的文献

1
Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany.评估德国成人序贯肺炎球菌疫苗接种计划的成本效益。
PLoS One. 2018 May 24;13(5):e0197905. doi: 10.1371/journal.pone.0197905. eCollection 2018.
2
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.23价肺炎球菌多糖疫苗（PPV23）对老年人肺炎球菌疾病的有效性：系统评价与荟萃分析
PLoS One. 2017 Jan 6;12(1):e0169368. doi: 10.1371/journal.pone.0169368. eCollection 2017.